Investment to establish the UKCRC Translational Infection Research Initiative has been committed by a partnership of seven funders: the Biotechnology and Biological Sciences Research Council, the Health Departments in England, Northern Ireland, Scotland and Wales, the Medical Research Council and Wellcome Trust.
The threat presented by readily transmissible infectious pathogens is well recognised by the public, policy-makers, healthcare practitioners and scientists. Persistent viral and bacterial infections are a significant burden for the NHS and for patients. Food-borne infections are a constant threat. So is the emergence of exotic viruses, and strains of known pathogens that have become resistant to current treatments. This initiative has been established to address these threats by moving forward research in this nationally important area.
The initiative will establish a number of Consortia with the potential to make a significant national impact. These will be major collaborative research groupings that will both conduct high quality, goal-oriented research and build academic capacity, training and infrastructure in the field. In addition the initiative will provide Strategy Development Grants to enable researchers to develop realistic and relevant research strategies and partnerships.
This initiative resulted from the work of a UKCRC planning group tasked with improving research into microbiology and infectious diseases in the UK. The group’s work included a consultation of key professional organisations in the field, examination of findings from recent major reviews in the area, and of other sources of evidence such as the UKCRC’s Health Research Analysis.
The group’s work resulted in the establishment of the UKCRC Translational Infection Research Initiative, which has three key aims, based on the evidence gathered from the review. These are the need to: